Compare RS & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RS | ASND |
|---|---|---|
| Founded | 1939 | 2006 |
| Country | United States | Denmark |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.4B | 16.2B |
| IPO Year | 1996 | 2014 |
| Metric | RS | ASND |
|---|---|---|
| Price | $389.00 | $246.94 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 16 |
| Target Price | ★ $358.00 | $281.50 |
| AVG Volume (30 Days) | 322.1K | ★ 462.3K |
| Earning Date | 04-22-2026 | 05-12-2026 |
| Dividend Yield | ★ 1.39% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 5.10 | N/A |
| Revenue | ★ $14,805,900,000.00 | N/A |
| Revenue This Year | $10.16 | $96.35 |
| Revenue Next Year | $0.82 | $44.91 |
| P/E Ratio | $76.80 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $260.31 | $186.05 |
| 52 Week High | $433.02 | $282.15 |
| Indicator | RS | ASND |
|---|---|---|
| Relative Strength Index (RSI) | 43.08 | 46.64 |
| Support Level | $390.05 | $238.09 |
| Resistance Level | $419.83 | $249.89 |
| Average True Range (ATR) | 12.47 | 6.64 |
| MACD | -3.80 | -0.24 |
| Stochastic Oscillator | 20.48 | 40.96 |
Reliance Inc operates a network of companies providing diversified metal solutions and is the metals service center company. It distributes a full line of over 100,000 metal products, including alloy, aluminum, brass, copper, carbon steel, stainless steel, titanium and other specialty steel products. The company services more than 125,000 customers in a variety of industries, including consumer products, general manufacturing, non-residential construction, transportation, aerospace, energy, electronics and semiconductor fabrication, industrial machinery and heavy industry. It also services the auto industry, through its toll processing operations where it processes customer-owned metal for a fee.
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.